Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi

Mathematical modelling study of first and second pregnancy informed by data from the Malawi Option B+ programme

From:
Foreign, Commonwealth & Development Office
Published
1 March 2016
Country:
Malawi
Document Type:
Discussion Paper
Theme:
Health
Authors:
Tweyaa, H, Keiserc, O, Haasc, Andreas D, Tenthanic Lyson, et all

Abstract

Study estimates the cost-effectiveness of prevention of mother to child transmission (MTCT) of HIV with lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women (‘Option B+’) compared to ART during pregnancy or breastfeeding only unless clinically indicated (‘Option B’).

This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

Hannock Tweyaa, Olivia Keiserc, Andreas D. Haasc, Lyson Tenthanic, Sam Phirib, Matthias Eggerc,Janne Estillc (2016) Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi AIDS. 2016 March 27; 30(6): 953–962. doi:10.1097/QAD.0000000000001009.

Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi

Updates to this page

Published 1 March 2016
Contents